BioNTech CEO Says 'Highly Likely' Vaccine Is Effective Against U.K. Virus Variant

Content Curator
A droplet falls from a syringe after a health care worker was injected with the Pfizer-BioNTech COVID-19 vaccine at Women & Infants Hospital in Providence, R.I.

"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," BioNTech CEO Ugur Sahin said Tuesday.

(Image credit: David Goldman/AP)